Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies

J Clin Immunol. 2021 Oct;41(7):1527-1530. doi: 10.1007/s10875-021-01101-8. Epub 2021 Jul 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • COVID-19 / immunology*
  • COVID-19 / therapy*
  • COVID-19 Vaccines / immunology*
  • Drug-Related Side Effects and Adverse Reactions
  • Female
  • Humans
  • Immunization, Passive
  • Immunologic Deficiency Syndromes / immunology*
  • Immunologic Deficiency Syndromes / therapy
  • Male
  • Middle Aged
  • SARS-CoV-2 / physiology*
  • Vaccination
  • Young Adult

Substances

  • COVID-19 Vaccines